Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Inflammatory Bowel Diseases

  Free Subscription


Articles published in Gastroenterol Hepatol

Retrieve available abstracts of 30 articles:
HTML format
Text format



Single Articles


    September 2017
  1. GONZALEZ ALAYON C, Pedrajas Crespo C, Marin Pedrosa S, Benitez JM, et al
    Prevalence of iron deficiency without anaemia in inflammatory bowel disease and impact on health-related quality of life.
    Gastroenterol Hepatol. 2017 Sep 9. pii: S0210-5705(17)30189.
    PubMed     Text format     Abstract available


  2. SANZ SANZ J, Juanola Roura X, Seoane-Mato D, Montoro M, et al
    Screening of Inflammatory Bowel Disease and Spondyloarthritis for Referring Patients Between Rheumatology and Gastroenterology.
    Gastroenterol Hepatol. 2017 Sep 4. pii: S0210-5705(17)30184.
    PubMed     Text format     Abstract available


    August 2017
  3. GUERRERO PUENTE L, Iglesias Flores E, Benitez JM, Medina Medina R, et al
    Evolution after switching to biosimilar infliximab in inflammatory bowel disease patients in clinical remission.
    Gastroenterol Hepatol. 2017 Aug 30. pii: S0210-5705(17)30182.
    PubMed     Text format     Abstract available


  4. AGUAS M, Del Hoyo J, Faubel R, Valdivieso B, et al
    Telemedicine in the treatment of patients with inflammatory bowel disease.
    Gastroenterol Hepatol. 2017 Aug 7. pii: S0210-5705(17)30166.
    PubMed     Text format     Abstract available


    July 2017
  5. TORRES P, Lobaton T, Canete F, Clos A, et al
    Cytomegalovirus primoinfection in inflammatory bowel disease.
    Gastroenterol Hepatol. 2017 Jul 19. pii: S0210-5705(17)30161.
    PubMed     Text format    


    June 2017
  6. AGUD FERNANDEZ M, Lopez Lopez F, Diaz Pedroche C, Gomez-Martin C, et al
    Concurrent inflammatory bowel disease and gastrointestinal stromal tumor.
    Gastroenterol Hepatol. 2017 Jun 24. pii: S0210-5705(17)30136.
    PubMed     Text format    


  7. DOMENECH E, Lopez-Sanroman A, Nos P, Vera M, et al
    Recommendations of the Spanish Working Group on Crohn's Disease and Ulcerative Colitis (GETECCU) on the monitoring, prevention and treatment of post-operative recurrence in Crohn's disease.
    Gastroenterol Hepatol. 2017 Jun 9. pii: S0210-5705(17)30126.
    PubMed     Text format     Abstract available


    December 2016
  8. MONTESERIN L, Jimenez M, Molina G, Reyes N, et al
    Colonic pseudopolyposis in inflammatory bowel disease.
    Gastroenterol Hepatol. 2016 Dec 21. pii: S0210-5705(16)30161.
    PubMed     Text format    


    September 2016
  9. GARCIA-LOPEZ S
    Inflammatory bowel disease in Digestive Disease Week 2016: advances in epidemiology, follow-up, treatment monitoring, optimisation and individual tailoring, and colon cancer prevention.
    Gastroenterol Hepatol. 2016;39 Suppl 1:29-35.
    PubMed     Text format     Abstract available


  10. CHAPARRO M
    Treatment of inflammatory bowel disease: what's new in Digestive Disease Week 2016.
    Gastroenterol Hepatol. 2016;39 Suppl 1:20-28.
    PubMed     Text format     Abstract available


  11. GOMOLLON F
    Treatment adherence is always worse than we think: an unresolved problem in inflammatory bowel disease.
    Gastroenterol Hepatol. 2016;39 Suppl 1:14-19.
    PubMed     Text format     Abstract available


    May 2016
  12. LOZOYA ANGULO ME, de Las Heras Gomez I, Martinez Villanueva M, Noguera Velasco JA, et al
    [Faecal calprotectin, an useful marker in discriminating between inflammatory bowel disease and functional gastrointestinal disorders].
    Gastroenterol Hepatol. 2016 May 31. pii: S0210-5705(16)30048.
    PubMed     Text format     Abstract available


  13. COLLAZO DIEGUEZ M, Gonzalez Carrera V
    [Foot drop during adalimumab therapy for Crohn disease].
    Gastroenterol Hepatol. 2016 May 13. pii: S0210-5705(16)30042.
    PubMed     Text format    


    March 2016
  14. MIRANDA-GARCIA P, Chaparro M, Gisbert JP
    Correlation between serological biomarkers and endoscopic activity in patients with inflammatory bowel disease.
    Gastroenterol Hepatol. 2016 Mar 25. pii: S0210-5705(16)30001.
    PubMed     Text format     Abstract available


  15. GINARD D, Khorrami S, Perez-Carazo L, Tavio-Hernandez E, et al
    [Efficacy and effectiveness of biologic therapy in inflammatory bowel disease. EFIFECT study].
    Gastroenterol Hepatol. 2016 Mar 18. pii: S0210-5705(16)00090.
    PubMed     Text format     Abstract available


  16. IRIARTE A, Zaera C, Bachiller-Corral J, Lopez-Sanroman A, et al
    [Inflammatory bowel disease as a paradoxical effect of anti-TNF alpha therapy].
    Gastroenterol Hepatol. 2016 Mar 15. pii: S0210-5705(16)00088.
    PubMed     Text format     Abstract available


  17. BATISTA L, Zabana Y, Aceituno M, Esteve M, et al
    Men in the spotlight: A rare case of penile squamous carcinoma associated with human papillomavirus (HPV) infection in a patient with ulcerative colitis (UC).
    Gastroenterol Hepatol. 2016 Mar 3. pii: S0210-5705(16)00037.
    PubMed     Text format    


    February 2016
  18. DOMENECH E, Gisbert JP
    [Efficacy and safety of vedolizumab in the treatment of ulcerative colitis].
    Gastroenterol Hepatol. 2016 Feb 29. pii: S0210-5705(16)00025.
    PubMed     Text format     Abstract available


  19. MUNOZ VILLAFRANCA C, Bravo Rodriguez MT, Ortiz de Zarate J, Arreba Gonzalez P, et al
    [Clinical outcome after discontinuation of infliximab in patients with ulcerative colitis in deep remission].
    Gastroenterol Hepatol. 2016 Feb 29. pii: S0210-5705(16)00026.
    PubMed     Text format     Abstract available


    January 2016
  20. AMO L, Gonzalez-Lama Y, Suarez C, Blazquez I, et al
    [Impact of the incorporation of a nurse in an inflammatory bowel disease unit].
    Gastroenterol Hepatol. 2016 Jan 27. pii: S0210-5705(15)00227.
    PubMed     Text format     Abstract available


    November 2015
  21. CHAPARRO M, Gisbert JP
    [New molecules in the treatment of inflammatory bowel disease].
    Gastroenterol Hepatol. 2015 Nov 26. pii: S0210-5705(15)00244.
    PubMed     Text format     Abstract available


  22. RUIZ-CUESTA P, Gonzalez-Alayon C, Jurado-Garcia J, Iglesias-Flores EM, et al
    Adherence to a predefined vaccination program in patients with inflammatory bowel disease.
    Gastroenterol Hepatol. 2015 Nov 18. pii: S0210-5705(15)00240.
    PubMed     Text format     Abstract available


  23. LOPEZ-IBANEZ M, Marin-Jimenez I
    [Drugs and anti-drug antibody levels in the management of patients with inflammatory bowel disease].
    Gastroenterol Hepatol. 2015 Nov 18. pii: S0210-5705(15)00236.
    PubMed     Text format    


    September 2015
  24. GARCIA-LOPEZ S
    [Epidemiology, follow-up, monitoring and other aspects of inflammatory bowel disease].
    Gastroenterol Hepatol. 2015;38 Suppl 1:32-8.
    PubMed     Text format     Abstract available


  25. CHAPARRO M
    [Natural history, complications, safety and pregnancy in inflammatory bowel disease].
    Gastroenterol Hepatol. 2015;38 Suppl 1:20-31.
    PubMed     Text format     Abstract available


    August 2015
  26. TINOCO R, Garcia E, Ramirez F, Correro F, et al
    [A case of de novo inflammatory bowel disease after liver transplantation for cryptogenic cirrhosis].
    Gastroenterol Hepatol. 2015 Aug 25. pii: S0210-5705(15)00167.
    PubMed     Text format    


  27. SENOSIAIN C, Gonzalez-Tallon A A, Lopez-Sanroman A, Mateos ML, et al
    Hepatitis E seroprevalence in inflammatory bowel disease.
    Gastroenterol Hepatol. 2015 Aug 6. pii: S0210-5705(15)00148.
    PubMed     Text format     Abstract available


    July 2015
  28. ALDEGUER X, Sicras-Mainar A
    Costs of ulcerative colitis from a societal perspective in a regional health care area in Spain: A database study.
    Gastroenterol Hepatol. 2015 Jul 23. pii: S0210-5705(15)00110.
    PubMed     Text format     Abstract available


    June 2015
  29. GISBERT JP, Gomollon F, Mendez I
    [Cost-effectiveness assessment through theoretical cost-minimization analysis of the use of two gastro-resistant modified-release mesalazine formulations in the management of ulcerative colitis in Spain].
    Gastroenterol Hepatol. 2015 Jun 10. pii: S0210-5705(15)00117.
    PubMed     Text format     Abstract available


    May 2015
  30. MARIN-JIMENEZ I, Gisbert JP, Perez-Calle JL, Garcia-Sanchez V, et al
    [Two-year incidence of new immune-mediated inflammatory diseases in patients with inflammatory bowel disease: A study in the AQUILES cohort].
    Gastroenterol Hepatol. 2015 May 13. pii: S0210-5705(15)00101.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Inflammatory Bowel Diseases is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: